A 2026 UK review of the 2024 Neurology cognition-and-stroke study, the 2025 Neurology prodromal-Parkinsons study (11+ servings a day, 2.5 risk), the 2026 dementia and systematic-review data, the NOVA classification and the UK SACN 2025 verdict, and the blood-sugar, gutbrain and inflammation mechanisms versus Dihexas unproven HGF/c-Met synaptogenesis, and why cutting UPF comes first, not a peptide Read the full review Nutritional & Metabolic Neuroscience 10 June 2026 Dihexa for Magnesium Deficiency Brain Fog: The 2025 Magnesium LThreonate Trial, the NMDABDNF Mechanism & the UK Review Can Dihexa help magnesium deficiency brain fog
Cachexia Sarcopenia Muscle 14 (3), 13651380
For the latest on that pipeline, Lilly is filing retatrutide for FDA approval in early 2027.
Weight loss medication isn't a quick fix
[12] Disclaimer: The products mentioned are not intended for human or animal consumption